Skip to main content
Article thumbnail
Location of Repository

Evaluation of Danazol, Cyclosporine, and Prednisolone as Single Agent or in Combination for Paroxysmal Nocturnal Hemoglobinuria

By Kanjaksha Ghosh, Manisha Madkaikar, Maya Gupta and Farah Jijina

Abstract

OBJECTIVE: The responses of 32 patients with paroxysmal nocturnal hemoglobinuria (PNH) were assessed after the patients were put on various combinations of danazol, prednisolone, and cyclosporine.\ud METHODS: Nineteen males and 13 females aged between 14 and 60 years with confirmed diagnosis of PNH were treated with danazol (4), danazol + cyclosporine (7), cyclosporine (1), and prednisolone + danazol (20). Response to these interventions was assessed regularly. Danazol was added to cyclosporine in patients with aplastic bone marrow after 3 months of cyclocporine use only unless the former therapy was successful. Four patients with aplastic marrow received only danazol because they had renal insufficiency at presentation. Patients were evaluated with regular complete blood count and routine liver and renal function tests.\ud RESULTS: One patient responded to cyclosporine only. Thirteen of 32 patients (40%) had complete response, 12/32 patients (37%) had partial response leading to freedom from red cell transfusion, and 2/32 (7%) had no response. Five patients (16%) died due to thrombosis or hemorrhage within 3 months of therapy before their response to therapy could be assessed. The median period of review of the cases was 4 years and 6 months.\ud CONCLUSION: Danazol is a useful addition to PNH therapy both in combination with cyclosporine for hypoplastic PNH and with prednisolone for other forms of PNH, and this therapy could be a good alternative where eculizumab and anti-lymphocyte globulin cannot be used for various reasons

Topics: Cyclosporine, Danazol, Hemoglobinuria, Paroxysmal, Immunosuppression, Prednisolone, Internal medicine, RC31-1245, Diseases of the blood and blood-forming organs, RC633-647.5
Publisher: Galenos Yayinevi
Year: 2013
DOI identifier: 10.4274/Tjh.2012.0199
OAI identifier: oai:doaj.org/article:e38cd860be5541708b2d8f6d7d0660ae
Journal:
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • https://doaj.org/toc/1308-5263 (external link)
  • https://doaj.org/toc/1300-7777 (external link)
  • http://dx.doi.org/10.4274/Tjh.... (external link)
  • https://doaj.org/article/e38cd... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.